Stereotaxis Inc. is an American publicly traded medical technology company based in St. Louis, Missouri, that makes robotic systems used by physicians to perform minimally-invasive endovascular procedures, including electrophysiology studies and cardiac catheter ablation procedures.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| STXS | Stereotaxis, Inc. | 2025-10-30 18:55:04 | 3.01 | 0.09 | 3.08 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STXS | 0001289340 | Stereotaxis, Inc. | US85916J4094 | 549300KPNOKI02O2ZP21 | 943120386 | NYSE | 3845 | Electromedical & Electrotherapeutic Apparatus | 1231 | DE | 710 N TUCKER BLVD | ST.LOUIS | MO | 63101 | UNITED STATES | US | 314-678-6100 | 710 N TUCKER BLVD, ST.LOUIS, MO, 63101 | 710 N TUCKER BLVD, ST.LOUIS, MO, 63101 | — | — | — | David L. Fischel | — | https://www.stereotaxis.com | 123,900,000 | 86,004,864 | 90,653,769 | Stereotaxis Inc. is an American publicly traded medical technology company based in St. Louis, Missouri, that makes robotic systems used by physicians to perform minimally-invasive endovascular procedures, including electrophysiology studies and cardiac catheter ablation procedures. | 2025-10-30 15:48:43 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2024 | 123,900,000 | 23,000,000 | 22.7948 | 85,979,662 | 3,850,900 | 4.6889 |
| 2023 | 100,900,000 | -9,800,000 | -8.8528 | 82,128,762 | 7,083,278 | 9.4386 |
| 2022 | 110,700,000 | -467,200,000 | -80.8444 | 75,045,484 | 407,178 | 0.5455 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| David L. Fischel | Chief Executive Officer | 2024 | 60,000 | — | 0 | 0 | 2,195 | 62,195 |
| Kimberly R. Peery | Chief Financial Officer | 2024 | 226,750 | — | 0 | 20,000 | 8,895 | 340,165 |
| Kimberly R. Peery | Chief Financial Officer | 2023 | 223,000 | — | 0 | 20,000 | 8,758 | 323,798 |
| David L. Fischel | Chief Executive Officer | 2023 | 60,000 | — | 0 | 0 | 2,195 | 62,195 |
| David L. Fischel | Chief Executive Officer | 2022 | 60,000 | — | 0 | 0 | 2,195 | 62,195 |
| Fiscal Year | Employee Count |
|---|---|
| 2024 | 139 |
| 2023 | 122 |
| 2022 | 130 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 26,918,000 | 26,771,000 | 28,147,000 |
| Cost Of Revenue | 12,324,000 | 11,911,000 | 9,677,000 |
| Gross Profit | 14,594,000 | 14,860,000 | 18,470,000 |
| Research And Development Expenses | 9,760,000 | 10,273,000 | 10,558,000 |
| General And Administrative Expenses | 17,201,000 | 14,050,000 | 14,363,000 |
| Operating Expenses | 39,333,000 | 36,699,000 | 37,246,000 |
| Operating Income | -24,739,000 | -21,839,000 | -18,776,000 |
| Net Income | -24,045,000 | -20,713,000 | -18,292,000 |
| Earnings Per Share Basic | -0.3 | -0.27 | -0.26 |
| Earnings Per Share Diluted | -0.3 | -0.27 | -0.26 |
| Weighted Average Shares Outstanding Basic | 85,183,306 | 80,702,358 | 76,061,183 |
| Weighted Average Shares Outstanding Diluted | 85,183,306 | 80,702,358 | 76,061,183 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash And Cash Equivalents | 12,217,000 | 19,818,000 | 8,586,000 |
| Marketable Securities Current | — | — | 19,844,000 |
| Accounts Receivable | 3,824,000 | 3,822,000 | 5,090,000 |
| Inventories | 8,331,000 | 8,426,000 | 7,876,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | — | — | — |
| Total Assets Current | 26,439,000 | 33,267,000 | 43,246,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 3,573,000 | 3,304,000 | 3,831,000 |
| Other Assets Non Current | — | — | — |
| Total Assets Non Current | 20,285,000 | 8,642,000 | 10,167,000 |
| Total Assets | 46,724,000 | 41,909,000 | 53,413,000 |
| Accounts Payable | 5,668,000 | 3,190,000 | 3,270,000 |
| Deferred Revenue | 6,804,000 | 6,657,000 | 7,342,000 |
| Short Term Debt | — | — | — |
| Other Liabilities Current | 2,922,000 | 2,972,000 | 3,306,000 |
| Total Liabilities Current | 21,602,000 | 13,247,000 | 14,291,000 |
| Long Term Debt | — | — | — |
| Other Liabilities Non Current | 64,000 | 43,000 | 51,000 |
| Total Liabilities Non Current | 13,690,000 | 6,742,000 | 7,193,000 |
| Total Liabilities | 35,292,000 | 19,989,000 | 21,484,000 |
| Common Stock | 85,000 | 81,000 | 75,000 |
| Retained Earnings | -561,725,000 | -537,680,000 | -516,967,000 |
| Accumulated Other Comprehensive Income | — | — | — |
| Total Shareholders Equity | 6,080,000 | 16,343,000 | 26,346,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Depreciation And Amortization | 382,000 | 595,000 | 429,000 |
| Share Based Compensation Expense | 10,262,000 | 10,623,000 | 10,576,000 |
| Other Non Cash Income Expense | — | — | — |
| Change In Accounts Receivable | -691,000 | -1,268,000 | -316,000 |
| Change In Inventories | -677,000 | 550,000 | 2,906,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | -29,000 | -71,000 | -70,000 |
| Change In Accounts Payable | 758,000 | 218,000 | -169,000 |
| Change In Other Liabilities | 21,000 | -8,000 | -167,000 |
| Cash From Operating Activities | -8,497,000 | -9,139,000 | -8,415,000 |
| Purchases Of Marketable Securities | — | — | 19,716,000 |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 34,000 | 366,000 | 2,378,000 |
| Acquisition Of Business | — | — | — |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | 74,000 | 19,765,000 | -22,094,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | 297,000 | 81,000 | 220,000 |
| Repurchase Of Common Stock | — | — | — |
| Issuance Of Long Term Debt | — | — | — |
| Repayment Of Long Term Debt | — | — | — |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | 297,000 | 81,000 | 220,000 |
| Change In Cash | -8,126,000 | 10,707,000 | -30,289,000 |
| Cash At End Of Period | 12,217,000 | 19,818,000 | 8,586,000 |
| Income Taxes Paid | — | — | — |
| Interest Paid | 694,000 | 1,096,000 | — |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Earnings Per Share | -0.3 | -0.27 | -0.26 |
| Price To Earnings Ratio | -7.6 | -6.4815 | -7.9615 |
| Earnings Growth Rate | 11.1111 | 3.8462 | 62.5 |
| Price Earnings To Growth Ratio | -0.684 | -1.6852 | -0.1274 |
| Book Value Per Share | 0.1342 | 0.2716 | 0.4198 |
| Price To Book Ratio | 16.989 | 6.4429 | 4.9311 |
| Ebitda | -22,969,000 | -19,022,000 | -17,379,000 |
| Enterprise Value | — | — | — |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | — | — | — |
| Capital Expenditures | 651,000 | 68,000 | 1,628,109 |
| Free Cash Flow | -9,148,000 | -9,207,000 | -10,043,109 |
| Return On Equity | -3.9548 | -1.2674 | -0.6943 |
| One Year Beta | 0.9283 | 0.4367 | 1.3612 |
| Three Year Beta | 1.1111 | 1.1206 | 1.0158 |
| Five Year Beta | 0.962 | 0.9814 | 0.9588 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| SHAMIR NACHUM | Director | 2025-07-01 | 43,668 | A | 89,276 |
| Menawat Arun Swarup | Director | 2025-07-01 | 43,668 | A | 945,509 |
| Curet Myriam | Director | 2025-07-01 | 43,668 | A | 345,110 |
| Benfer David | Director | 2025-07-01 | 43,668 | A | 468,924 |
| Levin Ross B | Director | 2025-07-01 | 43,668 | A | 531,197 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| AMALGAMATED BANK | 2025-09-30 | 6,000 | 1,897 | 3.1629 |
| WEALTH EFFECTS LLC | 2025-09-30 | 233,437 | 75,060 | 3.11 |
| Forum Financial Management, LP | 2025-09-30 | 82,471 | 26,518 | 3.11 |
| Roble, Belko & Company, Inc | 2025-09-30 | 31,000 | 10,000 | 3.1 |
| NISA INVESTMENT ADVISORS, LLC | 2025-09-30 | 25,592 | 8,229 | 3.11 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| PROSHARES TRUST | 2025-08-31 | ProShares Ultra Russell2000 | UWM | 5,796 | 16,692.48 | 0.0046 |
| PROSHARES TRUST | 2025-08-31 | ProShares Russell 2000 High Income ETF | ITWO | 1,213 | 3,493.44 | 0.0056 |
| PROSHARES TRUST | 2025-08-31 | ProShares Hedge Replication ETF | HDG | 71 | 204.48 | 0.0008 |
| PROSHARES TRUST | 2025-08-31 | ProShares Russell 2000 Dynamic Buffer ETF | RB | 78 | 224.64 | 0.0055 |
| PROSHARES TRUST | 2025-08-31 | ProShares UltraPro Russell2000 | URTY | 4,704 | 13,547.52 | 0.0035 |